[The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma].
Liu J, He HY, Li L, Lu J, Qiang WT, Guo P, Hou N, Jiang H, Du J, Fu WJ.
Liu J, et al. Among authors: qiang wt.
Zhonghua Xue Ye Xue Za Zhi. 2021 Jan 14;42(1):27-32. doi: 10.3760/cma.j.issn.0253-2727.2021.01.006.
Zhonghua Xue Ye Xue Za Zhi. 2021.
PMID: 33677865
Free PMC article.
Chinese.